- Nachrichtendetail
-
28.06.2024 08:04:08 - dpa-AFX: *ABBVIE GETS POSITIVE CHMP OPINION FOR EPCORITAMAB FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE | A1J84E | NYSE | 169,680 | 01.07.24 20:51:51 | -1,840 | -1,07% | 169,680 | 169,720 | 171,270 | 171,520 |
